Phyton Biotech And Insmed Sign Development Agreement - Quick Facts - Trading Markets
Published by Google Inc. July 31st, 2006 in Google FDA News, Regulatory Affairs
| Phyton Biotech And Insmed Sign Development Agreement - Quick Facts Trading Markets, CA - The company stated that the Food and Drug Administration approved IPLEX in December 2005 for the treatment of growth failure in children with severe primary IGF … Phyton Biotech Signs Development Agreement With Insmed |